Repligen Corp Share Price
NASDAQ: RGENHealthcare
Live Repligen Corp Share Price Chart
O H L
Repligen Corp Performance Overview
Days Range
▼
$176.62Low
$178.98High
Markets Today
| Previous Close | $178.19 |
|---|---|
| Open | $177.33 |
| Volume | 1,243,239 |
| Day's Range | $176.62 - $178.98 |
| 52W Range | $100.99 - $188.73 |
| Market Cap | $10.06 B |
Historical Performance
| 1M Returns | +0.30 |
|---|---|
| 3M Returns | +33.99 |
| 6M Returns | +50.40 |
| 1Y Returns | +44.64 |
| 5Y Returns | -42.20 |
| 10Y Returns | +432.16 |
Repligen Corp Fundamentals
| Market Cap | $10.06 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 242.89 |
| PEG Ratio | N/A |
| Revenue | $738.26 M |
| ROE TTM | 0.02 |
| EPS TTM | $0.73 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.76 |
| EBITDA | $135.47 M |
| Profit Margin | 6.62 |
| Market Cap | $10.06 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 242.89 |
| PEG Ratio | N/A |
| Revenue | $738.26 M |
| ROE TTM | 0.02 |
| EPS TTM | $0.73 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 4.76 |
| EBITDA | $135.47 M |
| Profit Margin | 6.62 |
Repligen Corp Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $169.17 M | $182.37 M | $188.81 M | $197.91 M | $194.25 M | $204.13 M |
| Gross Profit + | $91.37 M | $93.00 M | $100.52 M | $103.83 M | $108.28 M | $110.04 M |
| Operating Income | $6.58 M | $13.90 M | $16.82 M | $17.87 M | $15.94 M | $13.98 M |
| EBITDA | $27.25 M | $28.20 M | $37.90 M | $38.31 M | $37.05 M | $38.06 M |
| Interest Expense | -$5.25 M | -$5.35 M | -$5.83 M | -$4.25 M | -$5.58 M | -$5.66 M |
| Depreciation | $20.68 M | $14.30 M | $21.08 M | $20.44 M | $21.11 M | $24.09 M |
| Income Before Tax | $7.94 M | $18.21 M | $17.11 M | $19.11 M | $1.77 M | $14.15 M |
| Income Tax Expense | $2.11 M | $3.35 M | $2.20 M | $5.83 M | -$6.56 M | $9.14 M |
| Net Income + | $5.83 M | $14.87 M | $14.91 M | $13.29 M | $8.33 M | $5.01 M |
| Net Profit Margin | 3.45% | 8.15% | 7.9% | 6.71% | 4.29% | 2.45% |
Repligen Corp Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $562.00 K | $563.00 K | $563.00 K | $563.00 K | $564.00 K | $564.00 K |
| Reserve & Surplus | $365.34 M | $426.33 M | $438.85 M | $453.72 M | $450.27 M | $449.80 M |
| Non-Current Liabilities | $714.66 M | $716.87 M | $709.49 M | $707.74 M | $699.10 M | $705.49 M |
| Current Liabilities | $152.00 M | $123.01 M | $131.14 M | $135.83 M | $126.21 M | $132.66 M |
| Total Liabilities | $866.66 M | $839.89 M | $840.62 M | $843.57 M | $825.31 M | $838.15 M |
| Fixed Assets | $604.74 M | $599.70 M | $584.37 M | $572.76 M | $541.65 M | $525.13 M |
| Current Assets | $1.03 B | $1.06 B | $1.10 B | $1.14 B | $1.16 B | $1.20 B |
| Total Assets | $2.85 B | $2.90 B | $2.92 B | $2.95 B | $2.93 B | $2.95 B |
Repligen Corp Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | $5.83 M | $14.87 M | $14.91 M | $13.29 M | $8.33 M | $5.01 M |
| Operating Cash Flow | $15.01 M | $28.61 M | $48.10 M | $25.70 M | $28.30 M | $32.77 M |
| Investing Cash Flow | -$74.11 M | -$7.84 M | -$7.78 M | -$208.74 M | -$3.99 M | -$2.09 M |
| Financing Cash Flow | -$5.03 M | -$10.13 M | -$239.00 K | $195.00 K | -$5.54 M | -$6.20 M |
| Change in Cash | -$60.13 M | $11.63 M | $39.89 M | -$182.73 M | $18.62 M | $24.17 M |
Repligen Corp Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $149.38B | -34.65% | 37.86 | 14.71% | 0.75% |
 | $243.41B | 10.38% | 35.44 | 15.08% | 0.29% |
 | $44.08B | -8.68% | 30.81 | 18.75% | 0.65% |
 | $16.37B | NA | 69.88 | 8.45% | 0.19% |
 | $42.22B | 6.52% | 107.46 | 20.30% | 0.00% |
 | $28.26B | -8.83% | 31.75 | 21.59% | 0.00% |
 | $10.22B | -51.90% | 46.68 | 102.83% | 0.00% |
 | $11.36B | -45.26% | 62.53 | 14.97% | 0.44% |
Repligen Corp Return Calculator
The Repligen Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$4,411
Invested Amount$10,000
Est. Returns$-5,589
About Repligen Corp
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Popular Stocks
FAQs
What is the share price of Repligen Corp today?
Repligen Corp (RGEN) share price as of September 19, 2026 is $135.00. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Repligen Corp?
Yes, Indian Investors can invest in the Repligen Corp (RGEN) Share by opening an international trading account with Angel One.
How can I purchase Repligen Corp shares in India?
Purchasing Repligen Corp (RGEN) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Repligen Corp (RGEN) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Repligen Corp?
Yes, you can purchase fractional shares of Repligen Corp (RGEN) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Repligen Corp?
The market capitalization of Repligen Corp on September 19, 2026, is $10.06 B.
In which sector Repligen Corp belongs?
Repligen Corp operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Repligen Corp stocks?
In order to invest in Repligen Corp (RGEN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
